Putting the guidance into context, in FY2017, the second-half NPAT was 66% of first-half NPAT.
This year - using the mid-point of the $1.55bn to $1.60bn NPAT guidance - they are effectively saying that second-half NPAT will be just 45% of first-half NPAT.
And, put another way, this guidance implies an 8% decline in JH2018 NPAT vs JH2017.
Which suggests:
1. there is something skewiff with the business,
2. there is going to be the mother of ramp-up sin R&D expenditure, or
3. the guidance is very conservative
I have a decidedly firm view of which one of those possibilities will turn out to be the case.
- Forums
- ASX - By Stock
- CSL
- Ann: Half Year Results Analyst Presentation
Ann: Half Year Results Analyst Presentation, page-11
-
- There are more pages in this discussion • 180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$297.66 |
Change
-0.870(0.29%) |
Mkt cap ! $143.8B |
Open | High | Low | Value | Volume |
$297.59 | $298.49 | $296.08 | $171.9M | 578.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 277 | $297.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$297.67 | 169 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1714 | 297.600 |
2 | 83 | 297.500 |
2 | 945 | 297.320 |
1 | 75 | 297.250 |
1 | 945 | 297.160 |
Price($) | Vol. | No. |
---|---|---|
298.000 | 10 | 1 |
298.020 | 37 | 1 |
298.100 | 50 | 1 |
298.240 | 945 | 1 |
298.250 | 50 | 1 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online